TW201422254A - Composition for immediate and extended release - Google Patents

Composition for immediate and extended release Download PDF

Info

Publication number
TW201422254A
TW201422254A TW102140886A TW102140886A TW201422254A TW 201422254 A TW201422254 A TW 201422254A TW 102140886 A TW102140886 A TW 102140886A TW 102140886 A TW102140886 A TW 102140886A TW 201422254 A TW201422254 A TW 201422254A
Authority
TW
Taiwan
Prior art keywords
immediate
composition
extended release
active ingredient
controlled release
Prior art date
Application number
TW102140886A
Inventor
Varinder Ahuja
Rajan Verma
Umesh Vinayakrao Barabde
Arne Hagsten
Kristin Wannerberger
Rambabu Boorugu
Amol Vilasrao Somwanshi
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IN3575DE2012 priority Critical
Priority to IN3947DE2012 priority
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of TW201422254A publication Critical patent/TW201422254A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes

Abstract

The subject invention relates to fast dissolving pharmaceutical compositions comprising an active ingredient for immediate release and further comprising a controlled release dosage form comprising an active ingredient for controlled release.
TW102140886A 2012-11-21 2013-11-11 Composition for immediate and extended release TW201422254A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN3575DE2012 2012-11-21
IN3947DE2012 2012-12-20

Publications (1)

Publication Number Publication Date
TW201422254A true TW201422254A (en) 2014-06-16

Family

ID=49619947

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102140886A TW201422254A (en) 2012-11-21 2013-11-11 Composition for immediate and extended release

Country Status (18)

Country Link
EP (1) EP2922525A1 (en)
JP (1) JP2016500088A (en)
KR (1) KR20150085826A (en)
CN (1) CN104797240A (en)
AR (1) AR093585A1 (en)
AU (1) AU2013349682A1 (en)
BR (1) BR112015011430A2 (en)
CA (1) CA2891365A1 (en)
EA (1) EA201590805A1 (en)
HK (1) HK1213779A1 (en)
IL (1) IL238648D0 (en)
IN (1) IN2015DN03984A (en)
MX (1) MX2015006399A (en)
PH (1) PH12015501096A1 (en)
SG (2) SG11201503913TA (en)
TW (1) TW201422254A (en)
WO (1) WO2014079922A1 (en)
ZA (1) ZA201503603B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201805530RA (en) * 2015-09-30 2018-07-30 Wellesley Pharmaceuticals Llc Composition for reducing the frequency of urination, method of making and use thereof
KR20150144209A (en) * 2014-06-16 2015-12-24 훼링 비.브이. Pharmaceutical composition comprising stabilized desmopressin or pharmaceutically acceptable salt thereof
CN106999538A (en) 2014-11-20 2017-08-01 阿勒根公司 Methods and compositions comprising desmopressin in combination with alpha-adrenergic receptor antagonist
EP3244881A4 (en) * 2015-01-12 2018-08-15 Nano Pharmaceutical Laboratories LLC Layered sustained-release microbeads and methods of making the same
WO2018130603A1 (en) * 2017-01-11 2018-07-19 Ferring B.V. A fast disintegrating pharmaceutical composition
KR20190021180A (en) * 2017-08-22 2019-03-05 아주대학교산학협력단 Pharmaceutical complex formulations for treating neurodegenerative diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998003184A1 (en) 1996-07-19 1998-01-29 Clarke-Garegg, Margaret, A. Levan derivatives, their preparation, composition and applications including medical and food applications
SE9803871D0 (en) * 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic Method and Formulation
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthélabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
PT1501534E (en) * 2002-05-07 2006-09-29 Ferring Bv pharmaceutical formulations
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
CN100366294C (en) 2004-04-30 2008-02-06 量子高科(北京)研究院有限公司 Oral cavity quick dissolving preparation and production method thereof
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
WO2007029087A2 (en) 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Controlled release multiple unit formulations
US20090192228A1 (en) 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
CN102245171A (en) * 2008-11-10 2011-11-16 株式会社爱茉莉太平洋 Slow-release particle and a production method therefor
CA2769760A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Multi-layered, multiple unit pharmaceutical compositions
NZ706991A (en) * 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
JO3112B1 (en) * 2010-03-29 2017-09-20 Ferring Bv A fast dissolving pharmaceutical composition
MX356601B (en) * 2010-03-30 2018-05-29 Productos Maver S A De C V Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.
US20120135050A1 (en) * 2010-07-08 2012-05-31 Wellesley Pharmaceuticals, Llc Extended-release formulation for reducing the frequency of urination and method of use thereof

Also Published As

Publication number Publication date
SG11201503913TA (en) 2015-06-29
AU2013349682A1 (en) 2015-06-04
WO2014079922A1 (en) 2014-05-30
IL238648D0 (en) 2015-06-30
AR093585A1 (en) 2015-06-10
CA2891365A1 (en) 2014-05-30
EA201590805A1 (en) 2015-11-30
JP2016500088A (en) 2016-01-07
ZA201503603B (en) 2016-01-27
CN104797240A (en) 2015-07-22
HK1213779A1 (en) 2016-07-15
IN2015DN03984A (en) 2015-10-02
EP2922525A1 (en) 2015-09-30
MX2015006399A (en) 2015-07-21
KR20150085826A (en) 2015-07-24
PH12015501096A1 (en) 2015-07-27
BR112015011430A2 (en) 2017-07-11
SG10201703388TA (en) 2017-05-30

Similar Documents

Publication Publication Date Title
TW201336529A (en) Pharmaceutical dosage forms comprising poly( ε -caprolactone) and polyethylene oxide
ZA201406233B (en) Pharmaceutical composition and administration thereof
HK1206268A1 (en) Non linear multiblock copolymer drug conjugates for the delivery of active agents
PH12015501710B1 (en) Combination formulation of two antiviral compounds
EP3216448B8 (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
GB201106743D0 (en) Novel compounds
EP2522653A4 (en) Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
ME02189B (en) Controlled release pharmaceutical dosage forms
ZA201409291B (en) Biodegradable drug delivery for hydrophobic compositions
TW201431866A (en) Boronic acid derivatives and therapeutic uses thereof
IL235767A (en) Substituted pyrrolidines, pharmaceutical compositions comprising the same and uses thereof
SG10201703243QA (en) Inhalable pharmaceutical compositions
IL233663A (en) Indolizine compounds, processes for their preparation and pharmaceutical compositions containing them
SG187060A1 (en) C-met modulator pharmaceutical compositions
IL222738D0 (en) Pharmaceutical emulsion composition comprising progestogen
EP2931285A4 (en) Pharmaceutical compositions
IL236024A (en) Benzimidazole-proline derivatives and pharmaceutical compositions comprising them
CA2894892A1 (en) Boronic acid derivatives and therapeutic uses thereof
IL234466A (en) Triazolopyrazine derivatives, their preparation and pharmaceutical compositions containing them
ZA201407726B (en) Pharmaceutical compositions for combination therapy
EP2917180A4 (en) Gpr40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active ingredient
IL238713D0 (en) Self-regulated release of active pharmaceutical ingredient
IL235414A (en) Pyrrolotriazinone derivatives, their preparation and pharmaceutical compositions containing them
IL223983A (en) Heterocyclic alkynyl benzene compounds, medicinal compositions comprising them and uses thereof
EP2836072A4 (en) Herbicidal composition comprising uracil compound as active ingredient